Sherwin-Williams (NYSE:SHW) Price Target Raised to $370.00 at Barclays

Sherwin-Williams (NYSE:SHW) had its target price raised by Barclays from $355.00 to $370.00 in a research note released on Wednesday, Benzinga reports. The brokerage currently has an equal weight rating on the specialty chemicals company’s stock.

Other equities analysts also recently issued research reports about the stock. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research report on Thursday, July 18th. Evercore ISI increased their price target on shares of Sherwin-Williams from $365.00 to $380.00 and gave the stock an “outperform” rating in a report on Friday, August 30th. Morgan Stanley lifted their price objective on Sherwin-Williams from $375.00 to $450.00 and gave the company an “overweight” rating in a report on Friday, October 18th. The Goldman Sachs Group increased their target price on Sherwin-Williams from $344.00 to $390.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Finally, StockNews.com upgraded Sherwin-Williams from a “hold” rating to a “buy” rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Sherwin-Williams has an average rating of “Moderate Buy” and a consensus price target of $390.71.

Sherwin-Williams Price Performance

Shares of SHW opened at $362.72 on Wednesday. The company has a debt-to-equity ratio of 2.17, a current ratio of 0.81 and a quick ratio of 0.50. Sherwin-Williams has a 1-year low of $232.06 and a 1-year high of $392.57. The stock has a market cap of $91.50 billion, a PE ratio of 36.97, a price-to-earnings-growth ratio of 3.04 and a beta of 1.17. The firm has a fifty day moving average price of $371.81 and a 200 day moving average price of $334.64.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 EPS for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.19). Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The business had revenue of $6.16 billion during the quarter, compared to analyst estimates of $6.20 billion. During the same period in the previous year, the firm earned $3.20 earnings per share. The business’s revenue was up .7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Sherwin-Williams will post 11.49 EPS for the current year.

Sherwin-Williams Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.715 per share. The ex-dividend date is Friday, November 15th. This represents a $2.86 dividend on an annualized basis and a dividend yield of 0.79%. Sherwin-Williams’s dividend payout ratio (DPR) is 29.15%.

Insider Activity at Sherwin-Williams

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares of the company’s stock, valued at approximately $23,301,041.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.60% of the stock is owned by corporate insiders.

Institutional Trading of Sherwin-Williams

A number of large investors have recently made changes to their positions in the stock. HHM Wealth Advisors LLC boosted its stake in shares of Sherwin-Williams by 102.3% during the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 45 shares during the last quarter. Semmax Financial Advisors Inc. boosted its position in Sherwin-Williams by 136.4% during the second quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 60 shares during the last quarter. VitalStone Financial LLC grew its stake in Sherwin-Williams by 233.3% in the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 77 shares during the period. Anfield Capital Management LLC acquired a new position in Sherwin-Williams in the 2nd quarter valued at $38,000. Finally, Meeder Asset Management Inc. purchased a new position in shares of Sherwin-Williams during the 2nd quarter worth $41,000. Institutional investors and hedge funds own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.